AstraZeneca gets EU approvals after strong trial results
UK pharmaceutical giant AstraZeneca (AZN) announced two EU approvals for cancer drug Lynparza and strong efficacy data for lung cancer drug Tagrisso on Monday, but with the general market down over 3%, investors were in no mood to...
21 September 2020